We want to reduce the
transmission of resistant bacteria
in neonatal intensive care units
across Europe and globally.
We want to reduce the
transmission of resistant bacteria
across Europe and globally
Why this project
Nearly 1 in 10 newborns in Europe is admitted to a neonatal intensive care unit in the first days of life – that is around 400,000 admissions every year.
While care in a neonatal unit results in a greater chance of survival in newborns with serious illness, it also increases the risk of exposure to bacteria from the hospital environment. These can cause serious infections in babies, which are commonly resistant to many routinely used antibiotics.
The NeoIPC response
NeoIPC will identify best practices for the prevention of infections and surveillance of resistant bacteria in neonatal intensive care units in Europe. By conducting a clinical trial, the project will assess the safety and effectiveness of one or more specific, lowcost and simple interventions to prevent transmissions and infections with hospital bacteria in newborns.
Surveillance
Within the framework of the NeoIPC project, we have developed a surveillance system to contribute to the prevention and control of healthcare-associated infections in neonatology.
Governance
Led by the University of Padova, NeoIPC project consists of thirteen partners representing multiple institutions in Europe and Africa.
Latest project news
New Africa CDC Legal Framework for Infection Prevention and Control to support IPC in African hospitals
Africa CDC has joined forces with African Union (AU) Member States, the Infection Control Africa Network, U.S. CDC, and the World Health Organization to establish an Infection Prevention and Control (IPC) legal framework for AU Member States. This framework represents...
ECDC publishes epidemiological update on Echovirus 11 infection in newborns
On 19 July 2023, the European Centre for Disease Prevention and Control (ECDC) released an epidemiological update on the increase in severe neonatal Echovirus 11 (E11) infection among newborns in several European NICUs during the period between July 2022 and 2023.
Descriptive interim analysis of the sampling strategy in anonymous repeated cross-sectional samples in European neonatal intensive care units (NICU)
Authors: Golhen K, Gotta V, Pfister M, Bielicki J
Presented at: ESPID 2023
